These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1685032)

  • 1. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories.
    Caldecott-Hazard S; Morgan DG; DeLeon-Jones F; Overstreet DH; Janowsky D
    Synapse; 1991 Dec; 9(4):251-301. PubMed ID: 1685032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques.
    Caldecott-Hazard S; Guze BH; Kling MA; Kling A; Baxter LR
    Synapse; 1991 Jul; 8(3):185-211. PubMed ID: 1948669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.
    Caldecott-Hazard S; Schneider LS
    Synapse; 1992 Feb; 10(2):141-68. PubMed ID: 1585257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurobiological mechanisms in generalized anxiety disorder.
    Nutt DJ
    J Clin Psychiatry; 2001; 62 Suppl 11():22-7; discussion 28. PubMed ID: 11414547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of falling asleep. (Possibility of drug therapy in sleep disorders--participation of monoaminergic and gabaergic systems in the sleep-waking cycle)].
    Stock G
    Arzneimittelforschung; 1981; Suppl 27():15-7. PubMed ID: 6118157
    [No Abstract]   [Full Text] [Related]  

  • 7. Elucidation of biochemical basis of the antidepressant action of electroconvulsive therapy by human studies.
    Mann JJ; Kapur S
    Psychopharmacol Bull; 1994; 30(3):445-53. PubMed ID: 7878181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter hypotheses of depression. Research update.
    Jimerson DC
    Psychiatr Clin North Am; 1984 Sep; 7(3):563-73. PubMed ID: 6207513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of agitation.
    Lindenmayer JP
    J Clin Psychiatry; 2000; 61 Suppl 14():5-10. PubMed ID: 11154018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of our understanding of the mechanism of action of antidepressant drugs.
    Vetulani J
    Pol J Pharmacol Pharm; 1991; 43(4):323-38. PubMed ID: 1811223
    [No Abstract]   [Full Text] [Related]  

  • 12. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems.
    Adell A; Artigas F
    Neurosci Biobehav Rev; 2004 Jul; 28(4):415-31. PubMed ID: 15289006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rapid-eye-movement sleep disorders in Parkinson's disease].
    Gagnon JF; Montplaisir J; Bédard MA
    Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escalated aggressive behavior: dopamine, serotonin and GABA.
    de Almeida RM; Ferrari PF; Parmigiani S; Miczek KA
    Eur J Pharmacol; 2005 Dec; 526(1-3):51-64. PubMed ID: 16325649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT receptor regulation of neurotransmitter release.
    Fink KB; Göthert M
    Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoaminergic mechanisms in affective disorders.
    Syvälahti E
    Med Biol; 1987; 65(2-3):89-96. PubMed ID: 2888934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAergic dysfunction in mood disorders.
    Brambilla P; Perez J; Barale F; Schettini G; Soares JC
    Mol Psychiatry; 2003 Aug; 8(8):721-37, 715. PubMed ID: 12888801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G; Friedman A
    Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitters and sleep.
    Mendelson WB
    J Clin Psychiatry; 2001; 62 Suppl 10():5-8. PubMed ID: 11388591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.